WallStSmart

Braskem SA Class A (BAK)vsMethanex Corporation (MEOH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Braskem SA Class A generates 1720% more annual revenue ($66.75B vs $3.67B). MEOH leads profitability with a -1.2% profit margin vs -13.7%. MEOH appears more attractively valued with a PEG of 0.20. MEOH earns a higher WallStSmart Score of 60/100 (C).

BAK

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.5Value: 5.3Quality: 4.5
Piotroski: 3/9Altman Z: 0.13

MEOH

Buy

60

out of 100

Grade: C

Growth: 6.0Profit: 4.5Value: 6.3Quality: 4.5
Piotroski: 2/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BAK.

MEOHOvervalued (-6.1%)

Margin of Safety

-6.1%

Fair Value

$46.43

Current Price

$57.62

$11.19 premium

UndervaluedFair: $46.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BAK2 strengths · Avg: 10.0/10
EPS GrowthGrowth
107.2%10/10

Earnings expanding 107.2% YoY

Debt/EquityHealth
-4.3010/10

Conservative balance sheet, low leverage

MEOH3 strengths · Avg: 9.3/10
PEG RatioValuation
0.2010/10

Growing faster than its price suggests

EPS GrowthGrowth
78.1%10/10

Earnings expanding 78.1% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

BAK4 concerns · Avg: 2.5/10
Market CapQuality
$1.66B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-549.0%2/10

ROE of -549.0% — below average capital efficiency

Revenue GrowthGrowth
-20.4%2/10

Revenue declined 20.4%

MEOH4 concerns · Avg: 2.8/10
Return on EquityProfitability
0.6%3/10

ROE of 0.6% — below average capital efficiency

Debt/EquityHealth
1.433/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : BAK

The strongest argument for BAK centers on EPS Growth, Debt/Equity. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : MEOH

The strongest argument for MEOH centers on PEG Ratio, EPS Growth, Price/Book. PEG of 0.20 suggests the stock is reasonably priced for its growth.

Bear Case : BAK

The primary concerns for BAK are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : MEOH

The primary concerns for MEOH are Return on Equity, Debt/Equity, Piotroski F-Score.

Key Dynamics to Monitor

MEOH carries more volatility with a beta of 0.84 — expect wider price swings.

MEOH is growing revenue faster at 8.6% — sustainability is the question.

MEOH generates stronger free cash flow (110M), providing more financial flexibility.

Monitor CHEMICALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MEOH scores higher overall (60/100 vs 38/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Braskem SA Class A

BASIC MATERIALS · CHEMICALS · USA

Braskem SA produces and markets thermoplastic resins. The company is headquartered in Camaari, Brazil.

Methanex Corporation

BASIC MATERIALS · CHEMICALS · USA

Methanex Corporation produces and supplies methanol in North America, Asia Pacific, Europe, and South America. The company is headquartered in Vancouver, Canada.

Want to dig deeper into these stocks?